-+ 0.00%
-+ 0.00%
-+ 0.00%

AptarGroup's Aptar Pharma Reveals CE Marking For LuerVax

Benzinga·10/14/2026 21:05:19
Listen to the news

Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its LuerVax® intranasal delivery device and accompanying Spray Divider have been CE marked under the EU Medical Device Regulation (MDR), indicating that they meet the European general safety and performance requirements for medical devices. This milestone expands Aptar Pharma’s support for customers developing innovative intranasal vaccine products.